Trial NCT03598816

View at ClinicalTrials.gov 
Org. Study IDs: 202003083

Last trial update was posted on 2020-08-13

MeSH Interventions

Durvalumab Tremelimumab

MeSH Conditions

Carcinoma Carcinoma, Renal Cell

Other Conditions

Renal Cell Carcinoma

Stopping Reasons

FDA Contingencies unresolved

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID